Recent News

• 03.13.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.05.2025 - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 03.03.2025 - Syndax Fourth Quarter 2024 Conference Call
• 03.03.2025 - Syndax Fourth Quarter 2024 Conference Call
• 03.03.2025 - Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
• 03.03.2025 - Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
• 02.25.2025 - Syndax Announces Participation in March Investor Conferences
• 02.25.2025 - Syndax Announces Participation in March Investor Conferences
• 02.24.2025 - Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025

Recent Filings

• 03.04.2025 - 144 Report of proposed sale of securities
• 03.04.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.03.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.03.2025 - 8-K Current report
• 03.03.2025 - EX-99.1 EX-99.1
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.12.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors